You just read:

Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan

News provided by

Frost & Sullivan

Apr 26, 2012, 07:55 ET